Study of Single Nucleotide Polymorphisms Associated with Breast Cancer Patients among Arab Ancestries

Table 1

Histopathological and immunohistochemistry characteristics of breast cancer cases. Abbreviations: IDC: invasive ductal carcinoma; NOS: not otherwise specified; ILC: invasive lobular carcinoma; HER2/neu: human epidermal growth factor receptor 2.

Age (year-old)	Diagnosis	Estrogen receptors	Progesterone receptors	HER2/neu
55	IDC, NOS	Pos. 100%	Pos. 85%	Neg.
77	ILC, with pleomorphic features	Pos. >90%	Neg.	Neg.
60	IDC, NOS	Pos. 1%	Neg.	Neg.
68	IDC, NOS	Pos. 90%	Neg.	Neg.
53	IDC, NOS, with focal mucinous changes	Pos. 60%	Pos. 10%	Neg.
58	IDC, NOS	Pos. 70%	Pos. 65%	Neg.
51	IDC, NOS	Neg.	Neg.	Pos.
60	IDC, NOS	Pos. 100%	Pos. 80%	Neg.
33	IDC, NOS	Neg.	Neg.	Pos.
53	IDC, micropapillary type	Neg.	Neg.	Neg.
54	Invasive solid papillary carcinoma, with mucinous component	Pos. 95%	Pos. 95%	Neg.
66	IDC, NOS	Pos. 90%	Pos. 1%	Neg.
48	IDC, NOS	Pos. 90%	Pos. 90%	Neg.
45	IDC, NOS	Pos. 95%	Pos. 10%	Neg.
32	IDC, NOS	Pos.	Pos.	Neg.
56	IDC, with medullary features	Pos. 85%	Pos. 10%	Pos.
53	IDC, NOS	Pos. 85%	Neg.	Neg.
52	IDC, NOS	Pos. 90%	Pos. 40%	Neg.
39	Medullary carcinoma	Neg.	Neg.	Neg.
55	Mucinous carcinoma	Pos. 95%	Pos. 80%	Pos.
55	IDC, NOS	Pos. 80%	Pos. 80%	Pos.
38	Invasive carcinoma with neuroendocrine features	Pos. 90%	Pos 90%	Neg.
45	IDC, NOS	Neg.	Neg.	Neg.
63	IDC, NOS	Pos. 90%	Pos. 90%	Neg.
71	IDC, NOS	Pos. 90%	Pos. 5%	Neg.
64	IDC, NOS	Pos. 90%	Pos. 70%	Pos.